Craniomaxillofacial is a special branch of orthopedic surgery, which focuses on all the aspects of facial and skull disorders. The craniomaxillofacial implants surgery is carried out to treat a severe injury of facial and cranial bones, where the implants are temporarily or permanently placed in the body. Trauma, accidents, and genetic defects lead to craniomaxillofacial deformities. Craniomaxillofacial implants surgery is also carried out to correct abnormalities and deformities caused by diseases such as Crouzon’s disease and Apert’s Syndrome.
In early years, the emphasis was on maintaining absolute stability of bones, without much attention on free movements. However, owing to advancements in technology and implant materials such as biocompatible titanium implants, resorbable plates, screws, and bone grafts have increased the scope for maintaining stability as well as functionality of the joints, allowing for ease of treatments related to craniomaxillofacial deformities.
The global craniomaxillofacial implants market is estimated to be valued at US$ 2,289.5 million in 2019 and is expected to witness a robust CAGR of 6.2% over the forecast period (2019-2027).
Figure 1. Global Craniomaxillofacial Implants Market Share (%), By Application, (2019)
Source: Coherent Market Insights Analysis (2019)
Technological advancements in products and adoption of new technologies are expected to favor the global craniomaxillofacial implants market growth
Increasing technological advancements and application of 3D printing in healthcare industry has Influenced manufacturers to develop new innovative products, which is expected to drive the global craniomaxillofacial implants market growth. For instance, in September 2017, DePuy Synthes, a subsidiary of Johnson & Johnson Medical Devices, launched ‘TRUMATCH’ Titanium 3D-Printed Implants in the U.S., used for facial reconstruction.
Moreover, in October 2019, Zimmer Biomet Holdings Inc., a global manufacturer of musculoskeletal products, launched its ‘TrellOss-TC’ (TLIF curved), a 3D printed porous titanium interbody platform.
Rising cases of birth defects and abnormalities has resulted in increasing demand for craniomaxillofacial surgeries and expected to thrust the global craniomaxillofacial implants market growth over the forecast period
Many children are born with abnormalities such as structural defects, and the well-being of each child affected with a birth defect depends mostly on which organ or body part is involved and how much it is affected. Major birth defects such as cleft palate and anotia are treated through craniomaxillofacial surgeries. According to the Centers for Disease Control and Prevention (CDC) 2019 statistics, in the U.S., around 120,000 babies are recorded to be born with a birth defect every year. Moreover, according to the same source, 1 in every 2,800 babies are born with cleft lip or cleft palate in the U.S. and every year, 10,000 babies suffer from anotia.
Major factors restraining the global craniomaxillofacial implants market growth are high cost of these implants and product recalls by major manufacturers such as Stryker Corporation, which had recalled Custom Cranial Implant Kits, Johnson & Johnson, which recalled jaw implants, and DePuy Synthes, which recalled Craniomaxillofacial Distraction System.
Global Craniomaxillofacial Implants Market - Regional Analysis
On the basis of region, the global craniomaxillofacial implants market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold dominant position in the market, owing to presence of key players such as Stryker Corporation, Zimmer Biomet, Johnson & Johnson, and others in the region. These manufacturers are engaged in developing and launching new innovative products and offer huge portfolio of products used in craniomaxillofacial surgeries. This is expected to boost the global craniomaxillofacial implants market growth.
Asia Pacific is expected to witness high growth rate in the global craniomaxillofacial implants market during the forecast period, owing to rising expenditure on healthcare by the population and increasing rate of sports-related injuries. Such sports injuries, which require craniomaxillofacial surgeries include injuries related to nasal bone, facial fracture, mandibular fracture, and others. For instance, according to NCBI, a study reported that around 2,321 people reported with nasal bone and facial fractures caused by accidents and sport injuries in Seoul, Korea during 2010-2017.
Figure 2: Global Craniomaxillofacial Implants Market Share (%), By Region, (2019 & 2027)
Source: Coherent Market Insights (2019)
Global Craniomaxillofacial Implants Market – Competitive Landscape
Some of the major players operating in the global craniomaxillofacial implants market include Stryker Corporation, Johnson & Johnson, Zimmer Biomet Holdings, Inc., Medtronic Inc., Integra LifeSciences Holdings Corporation, OsteoMed L.P., Medartis AG, KLS Martin, Calavera Surgical Design, and Matrix Surgical USA.
Craniomaxillofacial implants are uplifting the healthcare industry by providing improved treatment options for facial and cranial injuries or any craniomaxillofacial abnormalities caused by several diseases such as Treacher Collins Syndrome, Apert's Syndrome, Crouzon's Syndrome, and others. Craniomaxillofacial includes area of the mouth, jaws, face, skull, and associated structures.
Increasing incidence of accidents lead to rising demand for craniomaxillofacial surgeries, which is expected to propel the global craniomaxillofacial implants market growth. Road traffic accidents is one of the major causes for increasing frequency of maxillofacial injuries including alveolar fractures, mandibular fractures and other. Increasing number of accidents is expected to increase the demand of craniomaxillofacial implants. For instance, according to the World Health Organization (WHO), in December 2018, around 54% of people suffered from injuries due to road traffic accidents, globally.
Availability of improved craniomaxillofacial implants materials and advent of new technologies associated with surgeries are expected to drive the global craniomaxillofacial implants market growth. Patient specific implants, 3D implants, rising demand for bioresorbable materials, and increasing adoption of robot assisted surgeries have simplified the complexity of craniomaxillofacial surgeries. Moreover, advanced techniques, including computer-assisted craniofacial reconstruction, distraction osteogenesis, and endoscopic procedures combined with refinements in surgical equipment such as resorbable plating and distractors have improved surgical outcomes while minimizing morbidity. The development of bone graft substitutes with the help of gene therapy and nanotechnology is also expected to drive the global craniomaxillofacial implants market growth.
For instance, in February 2016, the U.S. Food & Drug Administration (FDA) approved a 3D-printed, titanium, cranial/craniofacial patient-specific plate implant for use in the U.S.
3D printing technology is also enabling manufacturers to provide customized implants according to the requirement of patients, which makes the market more attractive. This is expected to propel the global craniomaxillofacial implants market growth.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.